By Bhanvi Satija and Puyaan Singh (Reuters) -Johnson & Johnson said on Monday it will buy neurological drugmaker ...

Medtronic (NYSE: MDT) announced today that it received CE mark approval for its BrainSense adaptive deep brian stimulation ...

A growing body of evidence points to synthetic chemicals as a threat to children's health.

Dyno Therapeutics announces exercise of option by Roche for next-generation AAV vector for neurological gene therapy ...

Johnson & Johnson said on Monday it would buy drugmaker Intra-Cellular Therapies for about $14.6 billion, boosting its ...

J&J will buy all of Intra-Cellular's shares for $132 apiece, representing a 39% premium to their Friday closing price. Shares ...

Dupree's new TLC show, "Baylen Out Loud," follows her journey with severe vocal and motor tics as she navigates adulthood, ...

The priority at Azara is dancers’ health. Founded in 2022 by the dancers Kate Flowers and Martin Roosaare, who are both ...

What Was Meant by The Descriptor “The New and Novel Complex Brain Therapy?” ...

Chronic stress weakens brain function and raises dementia risk. Discover how stress management can protect your mind.

Research reveals how herpes simplex virus-1 may contribute to Alzheimer’s disease, offering new insights into the disease’s ...

In an effort to close the gap in neurological outcomes for underserved populations, a UTHealth Houston project funded with $2.9 million from the National Institutes of Health (NIH) will engage ...